These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26778343)

  • 1. International Diabetes Federation World Diabetes Congress 2015.
    Gao HX; Regier EE; Close KL
    J Diabetes; 2016 May; 8(3):300-2. PubMed ID: 26778343
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing cardiovascular disease and diabetes: a call to action from the ADA and AHA.
    Wyne KL
    J Cardiometab Syndr; 2006; 1(3):220-1. PubMed ID: 17679801
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension in diabetes mellitus.
    Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
    Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 5. The heart in diabetes meeting.
    Bloomgarden Z
    J Diabetes; 2019 Nov; 11(11):840-841. PubMed ID: 31373114
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationships between cardiovascular disease and diabetes: focus on pathogenesis.
    Kovacic JC; Castellano JM; Farkouh ME; Fuster V
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):41-57. PubMed ID: 24582091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].
    ; Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer MJ; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I
    Rev Esp Cardiol; 2007 May; 60(5):1e-64e. PubMed ID: 17535764
    [No Abstract]   [Full Text] [Related]  

  • 8. Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.
    Cosentino F; Ceriello A; Baeres FMM; Fioretto P; Garber A; Stough WG; George JT; Grant PJ; Khunti K; Langkilde AM; Plutzky J; Rydén L; Scheen A; Standl E; Tuomilehto J; Zannad F
    Eur Heart J; 2019 Sep; 40(34):2907-2919. PubMed ID: 30445605
    [No Abstract]   [Full Text] [Related]  

  • 9. Update: standards of medical care in diabetes.
    Holcomb SS
    Nurse Pract; 2008 May; 33(5):12-5. PubMed ID: 18458622
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Alterations in Diabetes Mellitus: Workshop of the International Society for Heart Research XVth World Congress. Budapest, Hungary. Proceedings.
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S1-171. PubMed ID: 9044864
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perspective of simultaneous pancreas-kidney transplantation].
    Schenker P; Viebahn R
    Dtsch Med Wochenschr; 2013 May; 138(18):958-63. PubMed ID: 23613377
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk and diabetes mellitus management: diagnosis and treatment in special patient populations. Introduction.
    Garber AJ
    Am J Med; 2005 Apr; 118 Suppl 2():1S-2S. PubMed ID: 15903288
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
    Meerwaldt R; Links T; Zeebregts C; Tio R; Hillebrands JL; Smit A
    Cardiovasc Diabetol; 2008 Oct; 7():29. PubMed ID: 18840258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of what diabetes can do to your body (and what you can do to prevent it).
    Gebel E
    Diabetes Forecast; 2008 Dec; 61(12):45-6. PubMed ID: 19145747
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins and diabetes.
    Feeman WE
    Lancet; 2008 May; 371(9626):1752; author reply 1752. PubMed ID: 18502296
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy of diabetic dyslipidemia: do the statins suffice?
    Mooradian AD
    Am J Ther; 2015; 22(1):87-8. PubMed ID: 23728161
    [No Abstract]   [Full Text] [Related]  

  • 18. Do nitric oxide-releasing drugs offer a potentially new paradigm for the management of cardiovascular risks in diabetes?
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):533-6. PubMed ID: 24725228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the development of new PPAR agonists in diabetes.
    Cavender MA; Nicholls SJ; Lincoff AM
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic management of type 2 diabetes: how tight is right and how to get there.
    Nathan DM
    Arch Intern Med; 2008 Oct; 168(19):2064-6. PubMed ID: 18955633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.